Dravet Syndrome & Epilepsy

What is Dravet Syndrome?

Dravet syndrome, also known as Severe Myoclonic Epilepsy of Infancy (SMEI), is a rare and catastrophic form of intractable epilepsy that begins in infancy. Initial seizures are most often prolonged events and in the second year of life other seizure types begin to emerge. Development remains on track initially, with plateaus and a progressive decline typically beginning in the second year of life. Individuals with Dravet syndrome face a higher incidence of SUDEP (sudden unexplained death in epilepsy) and have associated conditions, which also need to be properly treated and managed. These conditions include:

behavior and developmental delays

movement and balance issues

orthopedic conditions

delayed language and speech issues

growth and nutrition issues

sleeping difficulties

chronic infections

sensory integration disorders

disruptions of the autonomic nervous system (which regulates things such as body temperature and sweating)

Children with Dravet Syndrome never outgrow this condition and it affects every aspect of their daily life.

Unless a cure or better treatments for Dravet syndrome and associated epilepsies are found, individuals with these disorders face a diminished quality of life. Current treatment options are extremely limited and the prognosis for these children is poor. The constant care and supervision of an individual with such highly specialized needs is emotionally and financially draining on the family members who care for these individuals.

Epilepsy is a medical condition that produces seizures affecting a variety of mental and physical functions. It’s also called a seizure disorder. When a person has two or more unprovoked seizures, they are considered to have epilepsy. Epilepsy can be caused by a vast array of things such as brain malformations, drug use, infections, genetics, progressive brain disorders, and more.